Hover over the bar plot to get the GO term. Differentially targeted genes and TFs were computed by comparing a cancer network to all other cancers.
Tool description
PANDA reconstructs a gene regulatory network using TF PPI, TF DNA binding motif, and gene expression samples. You can check the phenotypic information for the clinical variables of the samples that were used to reconstruct the network.
# | Tissue | Tool | netZoo release | Network |
PPI |
Motif | Expression | Regulator | nReg | Genes | Data | Samples | Precision |
Reference |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Uveal Melanoma | PANDA | netZooR 0.9 | TF | 644 | 29375 | TCGA | 80 | D |
Variable description
This is a description of the primary clinical variables of the gene expression samples that were used to generate the gene regulatory network.
Sample |
Gender | Race | Stage |
Vital status | Age |
Days to last follow up | Tumor ID |
---|---|---|---|---|---|---|---|
TCGA-V4-A9EF-01A | MALE | WHITE | Stage IIIB | Alive | 56 | 719 | UVM |
TCGA-YZ-A983-01A | FEMALE | WHITE | Stage IIB | Alive | 51 | 154 | UVM |
TCGA-V4-A9EK-01A | FEMALE | WHITE | Stage IIB | Alive | 37 | 567 | UVM |
TCGA-VD-AA8N-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 86 | 44 | UVM |
TCGA-V4-A9EI-01A | MALE | WHITE | Stage IIIB | Dead | 78 | [Not Available] | UVM |
TCGA-VD-A8KL-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 77 | 3 | UVM |
TCGA-VD-A8KM-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 65 | 4 | UVM |
TCGA-V4-A9EA-01A | MALE | WHITE | Stage IIIA | Alive | 66 | 751 | UVM |
TCGA-V4-A9E5-01A | FEMALE | WHITE | Stage IIIB | Alive | 51 | 1906 | UVM |
TCGA-WC-A885-01A | MALE | WHITE | Stage IIA | Alive | 60 | 315 | UVM |
TCGA-VD-AA8O-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 77 | 228 | UVM |
TCGA-VD-A8K8-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 56 | 20 | UVM |
TCGA-YZ-A982-01A | FEMALE | WHITE | Stage IIIB | Alive | 79 | 159 | UVM |
TCGA-VD-A8KK-01A | MALE | [Not Evaluated] | Stage IIIA | Alive | 54 | 3 | UVM |
TCGA-V4-A9EE-01A | MALE | WHITE | Stage IIB | Dead | 86 | [Not Available] | UVM |
TCGA-V4-A9E7-01A | MALE | WHITE | Stage IIIA | Dead | 76 | [Not Available] | UVM |
TCGA-V4-A9EY-01A | FEMALE | WHITE | Stage IIIA | Alive | 66 | 405 | UVM |
TCGA-WC-A883-01A | FEMALE | WHITE | Stage IIIA | Dead | 76 | [Not Available] | UVM |
TCGA-V4-A9EQ-01A | MALE | WHITE | Stage IIIA | Dead | 64 | [Not Available] | UVM |
TCGA-V3-A9ZY-01A | MALE | WHITE | Stage IIB | Alive | 54 | 123 | UVM |
TCGA-VD-A8KA-01B | MALE | [Not Evaluated] | Stage IIB | Alive | 22 | 842 | UVM |
TCGA-V4-A9EU-01A | FEMALE | WHITE | Stage IIIC | Alive | 83 | 709 | UVM |
TCGA-V4-A9EM-01A | MALE | WHITE | Stage IIIA | Alive | 53 | 488 | UVM |
TCGA-VD-A8KI-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 68 | 38 | UVM |
TCGA-V4-A9EL-01A | MALE | WHITE | Stage IIIA | Alive | 60 | 583 | UVM |
TCGA-V4-A9F2-01A | FEMALE | WHITE | Stage IIIA | Alive | 78 | 371 | UVM |
TCGA-V3-A9ZX-01A | MALE | WHITE | Stage IIB | Alive | 56 | 137 | UVM |
TCGA-V4-A9F8-01A | MALE | WHITE | Stage IIIA | Alive | 68 | 582 | UVM |
TCGA-V4-A9EH-01A | MALE | WHITE | Stage IIIB | Alive | 53 | 670 | UVM |
TCGA-V4-A9F0-01A | MALE | WHITE | Stage IIIB | Alive | 59 | 607 | UVM |
TCGA-V4-A9F3-01A | FEMALE | WHITE | Stage IIIA | Alive | 49 | 525 | UVM |
TCGA-VD-AA8M-01A | MALE | [Not Evaluated] | Stage IIA | Alive | 64 | 6 | UVM |
TCGA-WC-A88A-01A | MALE | WHITE | Stage IV | Dead | 75 | [Not Available] | UVM |
TCGA-VD-A8KF-01A | MALE | [Not Evaluated] | Stage IIIB | Dead | 68 | [Not Available] | UVM |
TCGA-VD-AA8S-01B | MALE | [Not Evaluated] | Stage IIA | Alive | 40 | 245 | UVM |
TCGA-WC-A87W-01A | FEMALE | WHITE | Stage IIA | Alive | 57 | 977 | UVM |
TCGA-V4-A9E9-01A | MALE | WHITE | Stage IIIA | Alive | 50 | 767 | UVM |
TCGA-VD-A8KB-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 66 | 660 | UVM |
TCGA-WC-A888-01A | MALE | WHITE | Stage IIB | Alive | 76 | 52 | UVM |
TCGA-V4-A9F5-01A | FEMALE | WHITE | Stage IV | Alive | 85 | 202 | UVM |
TCGA-VD-A8K9-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 71 | 14 | UVM |
TCGA-V4-A9ES-01A | FEMALE | WHITE | Stage IIIA | Alive | 54 | 1027 | UVM |
TCGA-WC-A87Y-01A | MALE | WHITE | [Not Available] | Alive | 59 | 369 | UVM |
TCGA-VD-AA8P-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 64 | 86 | UVM |
TCGA-V4-A9EV-01A | FEMALE | WHITE | Stage IIIA | Alive | 59 | 836 | UVM |
TCGA-YZ-A985-01A | FEMALE | WHITE | Stage IIIA | Alive | 41 | 599 | UVM |
TCGA-V4-A9ET-01A | MALE | WHITE | Stage IIIB | Alive | 57 | 872 | UVM |
TCGA-VD-A8KD-01A | MALE | [Not Evaluated] | Stage IV | Dead | 72 | [Not Available] | UVM |
TCGA-VD-A8KJ-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 53 | 961 | UVM |
TCGA-V4-A9EO-01A | MALE | WHITE | Stage IIIA | Alive | 74 | 407 | UVM |
TCGA-V4-A9F4-01A | MALE | WHITE | Stage IIIA | Alive | 41 | 256 | UVM |
TCGA-VD-AA8R-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 78 | 2 | UVM |
TCGA-V4-A9F7-01A | FEMALE | WHITE | Stage IIB | Alive | 78 | 927 | UVM |
TCGA-WC-A881-01A | MALE | WHITE | Stage IIB | Alive | 75 | 694 | UVM |
TCGA-WC-A882-01A | FEMALE | WHITE | Stage IIB | Alive | 50 | 344 | UVM |
TCGA-WC-A880-01A | MALE | WHITE | Stage IIIA | Alive | 63 | 842 | UVM |
TCGA-WC-A87T-01A | MALE | WHITE | Stage IIB | Alive | 64 | 2149 | UVM |
TCGA-WC-AA9E-01A | MALE | WHITE | Stage IIA | Alive | 60 | 315 | UVM |
TCGA-VD-A8KG-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 47 | 19 | UVM |
TCGA-WC-AA9A-01A | FEMALE | WHITE | Stage IIA | Dead | 70 | [Not Available] | UVM |
TCGA-YZ-A980-01A | MALE | WHITE | Stage IIIA | Alive | 75 | 1283 | UVM |
TCGA-VD-A8KN-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 60 | 7 | UVM |
TCGA-VD-A8KO-01A | MALE | [Not Evaluated] | Stage IIA | Alive | 51 | 26 | UVM |
TCGA-VD-A8KH-01A | MALE | [Not Evaluated] | Stage IIIB | Alive | 69 | 10 | UVM |
TCGA-V4-A9EW-01A | FEMALE | WHITE | Stage IIIA | Alive | 44 | 774 | UVM |
TCGA-RZ-AB0B-01A | FEMALE | WHITE | Stage IV | Dead | 47 | [Not Available] | UVM |
TCGA-VD-A8KE-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 74 | 6 | UVM |
TCGA-V4-A9F1-01A | FEMALE | WHITE | Stage IIB | Alive | 46 | 556 | UVM |
TCGA-V4-A9EX-01A | FEMALE | WHITE | Stage IIIA | Dead | 55 | [Not Available] | UVM |
TCGA-YZ-A984-01A | FEMALE | WHITE | Stage IIB | Alive | 50 | 946 | UVM |
TCGA-VD-AA8T-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 83 | 49 | UVM |
TCGA-V4-A9EJ-01A | MALE | WHITE | Stage IIB | Alive | 38 | 382 | UVM |
TCGA-VD-AA8Q-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 71 | 2 | UVM |
TCGA-V4-A9EC-01A | FEMALE | WHITE | Stage IIB | Alive | 75 | 743 | UVM |
TCGA-VD-A8K7-01B | MALE | [Not Evaluated] | Stage IIIA | Alive | 39 | 3 | UVM |
TCGA-V4-A9EZ-01A | FEMALE | WHITE | Stage IIB | Alive | 78 | 599 | UVM |
TCGA-V4-A9E8-01A | MALE | WHITE | Stage IIIA | Dead | 49 | [Not Available] | UVM |
TCGA-V4-A9ED-01A | MALE | WHITE | Stage IIIA | Alive | 45 | 654 | UVM |
TCGA-WC-A87U-01A | MALE | WHITE | Stage IIIA | Dead | 73 | [Not Available] | UVM |
TCGA-WC-A884-01A | FEMALE | WHITE | Stage IIIB | Alive | 35 | 12 | UVM |
Sample | Gender | Race | Stage | Status | Age | Days to follow up | Tumor ID |